Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016632 (
Fox
)
1,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The precise regulation of many alternative splicing (AS) events by specific splicing factors is essential to determine tissue types and developmental stages. However, the molecular basis of tissue-specific AS regulation and the properties of splicing regulatory networks (SRNs) are poorly understood. Here we comprehensively predict the targets of the brain- and muscle-specific splicing factor
Fox
-1 (A2BP1) and its paralog Fox-2 (
RBM9
) and systematically define the corresponding SRNs genome-wide.
Fox
-1/2 are conserved from worm to human, and specifically recognize the RNA element UGCAUG. We integrate
Fox
-1/2-binding specificity with phylogenetic conservation, splicing microarray data, and additional computational and experimental characterization. We predict thousands of
Fox
-1/2 targets with conserved binding sites, at a false discovery rate (FDR) of approximately 24%, including many validated experimentally, suggesting a surprisingly extensive SRN. The preferred position of the binding sites differs according to AS pattern, and determines either activation or repression of exon recognition by
Fox
-1/2. Many predicted targets are important for neuromuscular functions, and have been implicated in several genetic diseases. We also identified instances of binding site creation or loss in different vertebrate lineages and human populations, which likely reflect fine-tuning of gene expression regulation during evolution.
...
PMID:Defining the regulatory network of the tissue-specific splicing factors Fox-1 and Fox-2. 1879 51
The
Fox
proteins are a family of regulators that control the alternative splicing of many exons in neurons, muscle, and other tissues. Each of the three mammalian paralogs,
Fox
-1 (A2BP1), Fox-2 (
RBM9
), and
Fox
-3 (HRNBP3), produces proteins with a single RNA-binding domain (RRM) flanked by N- and C-terminal domains that are highly diversified through the use of alternative promoters and alternative splicing patterns. These genes also express protein isoforms lacking the second half of the RRM (FoxDeltaRRM), due to the skipping of a highly conserved 93-nt exon.
Fox
binding elements overlap the splice sites of these exons in
Fox
-1 and Fox-2, and the
Fox
proteins themselves inhibit exon inclusion. Unlike other cases of splicing autoregulation by RNA-binding proteins, skipping the RRM exon creates an in-frame deletion in the mRNA to produce a stable protein. These FoxDeltaRRM isoforms expressed from cDNA exhibit highly reduced binding to RNA in vivo. However, we show that they can act as repressors of
Fox
-dependent splicing, presumably by competing with full-length
Fox
isoforms for interaction with other splicing factors. Interestingly, the Drosophila
Fox
homolog contains a nearly identical exon in its RRM domain that also has flanking
Fox
-binding sites. Thus, rather than autoregulation of splicing controlling the abundance of the regulator, the
Fox
proteins use a highly conserved mechanism of splicing autoregulation to control production of a dominant negative isoform.
...
PMID:Autoregulation of Fox protein expression to produce dominant negative splicing factors. 2004 73
RBFOX2 (RNA-binding protein,
Fox
-1 homologue 2)/
RBM9
(RNA-binding-motif protein 9)/RTA (repressor of tamoxifen action)/HNRBP2 (hexaribonucleotide-binding protein 2) encodes an RNA-binding protein involved in tissue specific alternative splicing regulation and steroid receptors transcriptional activity. Its ability to regulate specific splicing profiles depending on context has been related to different expression levels of the RBFOX2 protein itself and that of other splicing regulatory proteins involved in the shared modulation of specific genes splicing. However, this cannot be the sole explanation as to why RBFOX2 plays a widespread role in numerous cellular mechanisms from development to cell survival dependent on cell/tissue type. RBFOX2 isoforms with altered protein domains exist. In the present article, we describe the main RBFOX2 protein domains, their importance in the context of splicing and transcriptional regulation and we propose that RBFOX2 isoform distribution may play a fundamental role in RBFOX2-specific cellular effects.
...
PMID:RBFOX2 protein domains and cellular activities. 2511 22